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Abstract  
Background: Structural neuroimaging studies revealed a consistent pattern of volumetric 
reductions in both hippocampus (HC) and anterior cingulate cortex (ACC) of individuals with 
major depressive episode(s) (MDE). This study investigated HC and ACC volume differences 
in currently depressed individuals (n=150) and individuals with a past lifetime MDE history 
(n=79) versus healthy controls (n=287). Methods: Non-demented individuals were recruited 
from a cohort of community-dwelling older adults (ESPRIT study). T1-weighted magnetic 
resonance images and FreeSurfer Software (automated method) were used. Concerning HC, a 
manual method of measurement dividing HC into head, body, and tail was also used. General 
Linear Model was applied adjusting for covariates. Results: Current depression was 
associated with lower left posterior HC volume, using manual measurement, in comparison to 
healthy status. However, when we slightly changed sub-group inclusion criteria, results did 
not survive to correction for multiple comparisons. Conclusions: The finding of lower left 
posterior HC volume in currently depressed individuals but not in those with a past MDE 
compared to healthy controls could be related to brain neuroplasticity. Additionally, our 
results may suggest manual measures to be more sensitive than automated methods. 
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1. Introduction 
According to the World Health Organization, the overall prevalence rate of depressive 
disorders among older adults ranges from 8 to 20% in the community and up to 37% in 
primary care (World Health Organization, 2001). Recurrent and chronic major depression is 
associated with high levels of morbidity and functional impairment (McMahon, 2012). 
Duration of depression appears to be associated with the extent of global cerebral gray matter 
change (Lampe, 2003). Structural magnetic resonance imaging (MRI) has been widely used to 
examine the neuro-structural correlates of depression, in young and elderly populations 
(Schweitzer, 2001). Meta-analyses of volumetric MRI studies in patients with unipolar 
depression in comparison with healthy controls have shown volume reductions in the 
hippocampus (HC) (Campbell, 2004; McKinnon, 2009; Videbech, 2004), the subgenual 
cortex (Bora, 2012), the amygdala (Hamilton, 2008), the putamen and the caudate nucleus 
(Koolschijn, 2009), and the right cingulate cortex (Arnone, 2012). The most frequently 
observed regions of atrophy are the HC, the anterior cingulate cortex (ACC), the prefrontal 
cortices, the striatum, the amygdala (Du, 2014) and the thalamus (Andreescu, 2008). Among 
them two limbic structures, the HC and the ACC, seem particularly consistent (Ballmaier, 
2004; Steffens, 2000). In particular, HC volume reduction has been repeatedly reported in 
neuroimaging studies of depressed patients (Campbell, 2014; Malykhin, 2015; Schmaal, 
2015; Y. I. Sheline, 1996), including older adults (Ballmaier, 2008; Hickie, 2005; Lloyd, 
2004; O'Brien, 2004; Y. I. Sheline, 1996; Steffens, 2000). This reduction could be due to 
stress, through increased glucocorticoid release which in turn suppresses adult neurogenesis in 
the dentate gyrus (a HC sub-region) eventually promoting onset of a depressive episode 
(Eker, 2010; Jacobs, 2000; Sapolsky, 1986). However, HC volume reduction in late life 
depression (LLD) may also be linked to neurodegenerative disorders, like Alzheimer's 
disease, in an early or pre-clinical stage (de Flores, 2015). ACC volumes as well seem to 
decrease in major depressive disorder (MDD) in adulthood (Arnone, 2012; Bora, 2012) but 
also in LLD (Ballmaier, 2004; Gunning, 2009). This region may play a key role in functions 
disrupted in depression in older adults as it is connected to brain structures that regulate 
mood, emotional valence of thought and autonomic and visceral responses (George S. 
Alexopoulos, 2008). 
Brain volume changes due to depression in older adults may be modified by a number of 
confounding factors. First, female gender (Mulsant, 1999) and past history of depression seem 
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to increase the risk of LLD (Cole, 2014). Second, magnitude of brain volume reduction has 
been associated with the severity of the depressive episode (Lorenzetti, 2009; Vakili, 2000). 
Third, longitudinal studies have shown that cardiovascular risk factors pertaining to the 
metabolic syndrome increase the risk of LLD (George S. Alexopoulos, 2005; Krishnan, 2002; 
Laks, 2010; Reaven, 1988). Finally, antidepressant use reduces time to recovery (G. S. 
Alexopoulos, 1996) and induces brain plasticity especially in prefrontal cortex, ACC, and 
medial temporal areas (Bellani, 2011).  
In order to further understand the differences between currently depressed individuals and 
persons with past major depressive episode (MDE), who may have recovered in terms of 
brain atrophy, we investigated the volume differences in the HC and ACC in a general 
population sample of French older adults. The aim of the present study was to compare HC 
and ACC volumes in older adults with current or past depression versus healthy controls. To 
this end we focused on regional reconstruction and segmentation of both regions obtained 
through FreeSurfer image analysis suite (automated method). Manual HC volume estimation 
was also undertaken. We hypothesized that HC and ACC volumes would be reduced in 
depressed older adults controlling for potential confounders, such as gender, metabolic 
syndrome and antidepressant use. 
 
2. Materials and methods  
 
2.1 Sample 
We used data from a prospective study of psychiatric disorders in older adults’ community 
dwellers (the “Enquête de Santé Psychologique – Risques, Incidence et Traitement”, or 
ESPRIT study). In this project, 1863 subjects aged 65 and over were randomly recruited from 
the 15 electoral rolls of Montpellier district (South of France) between March 1999 and 
February 2001 (Ritchie, 2004). Participants underwent clinical, biological and neuroimaging 
assessment administered by trained staff at the Gui de Chauliac Neurology Hospital of 
Montpellier. Ethical approval was obtained by the ethics committee and written informed 
consent was collected from all the participants. For the current study, we selected individuals 
aged ≤ 80 with available MRI imaging data, specifically of estimated HC, ACC and total 
intracranial volumes (n=661). We then excluded participants with a diagnosis of dementia 
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(n=15), with missing baseline Mini International Neuropsychiatric Interview (MINI) data 
(n=16), and with MINI diagnosis other than depression (n=114). A total of 516 individuals 
were finally retained (see Figure 1 for the flow chart). 
 
2.2 Assessment  
Participants completed a standardized interview covering socio-demographic characteristics 
along with a general health questionnaire about medical history, medications, current alcohol 
consumption, and tobacco use. Psychiatric diagnoses, including current and lifetime MDE, 
were assessed using the Mini International Neuropsychiatric Interview (MINI; French version 
5.00), validated in the general population and providing DSM-IV diagnoses (Sheehan, 1998). 
The MINI was administered by trained interviewers (nurses and psychologists) and positive 
cases were reviewed by a clinical panel of psychiatrists. The Centre for Epidemiologic Studies 
- Depression Scale (CES-D) (Radloff, 1977) was used to assess the severity of depressive 
symptoms. A standardized neurological examination, based on the International Classification 
of Diseases (ICD-10) criteria (World Health Organization, 1992), was used for the diagnosis 
of dementia. Preliminary diagnosis of dementia was made by a neurologist and validated by 
an independent national panel of neurologists to obtain consensus. 
 
2.3 Study groups 
In older adults, clinically significant depressive symptomatology does not always correspond 
to the criteria for major depression of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV) (Büchtemann, 2012), although it has similar consequences on well-being 
and functioning. As one definition alone (categorical versus dimensional) does not adequately 
capture the current late life depression construct, we based our current depression assessment 
on the three following criteria: 1) a diagnosis of current MDE at the MINI (onset within the 
past two weeks) according to the DSM-IV criteria, and/or 2) a CES-D cutoff score ≥16 to 
account for subsyndromal depressive symptomatology, the clinical significance of which, 
among older primary care patients, has been demonstrated and which poses substantially 
elevated risk of persistent depressive symptoms and worsening into major depression (Lyness, 
2009), and/or 3) current antidepressant treatment according to the medications’ record. While 
recognizing that in few cases antidepressants could have been prescribed for other reasons 
(e.g., anxiety or insomnia), we considered that this group could not be excluded as the 
subjects were likely not to show depressive symptomatology any longer due to the treatment, 
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but they could still manifest underlying physiological changes.. Identified current depressive 
older adults were n=150. Past depression was determined by the presence of MDE history at 
the MINI according to DSM-IV criteria and no current late life depression (to avoid 
overlapping between the groups). Identified past MDE older adults were n=79. Healthy 
controls were n=287, they had no past  MDE or current late life depression or any other 
psychiatric disorder screened with the MINI. They had a CESD<15 and no antidepressant use. 
 
2.4 Other measures  
Metabolic syndrome was defined using the National Cholesterol Education Program Adult 
Treatment Panel III criteria (Grundy, 2005). Details of procedures have been previously 
described (Akbaraly, 2011; Carriere, 2014). 
 
2.5 Imaging analyses  
Anatomical scans were acquired in the period 1999-2001. A 1.5 T GE Signa Imaging System 
(General Electric Medical Systems, Milwaukee, WI) was used to acquire a contiguous AC-PC 
aligned axial IR-prepared SPGR T1-weighted sequence for volumetric estimations (TR=12, 
TE=2.8, IT=600, matrix size=256×256, pixel spacing=0.9375×0.9375 mm, NEX=1, slice 
thickness=1.0 mm).  
 
2.5.1 Automated measurements for HC and ACC 
Regional reconstruction and segmentation was performed with the FreeSurfer, version 6.0, 
image analysis suite (http://surfer.nmr.mgh.harvard.edu/). This contains several stages, the 
first of which comprised the reconstruction of the cortical surface (Dale, 1999). Normalized 
intensity images were created, corrected for the variations in intensity due to magnetic field 
inhomogeneity. Voxels beyond the cerebral cortex, namely the skull, were then removed 
before segmentation initiated. Segmentation is based on the geometric structure where grey 
and white matter interface, and subsequently separates the left and right hemispheres as well 
as cortical from subcortical structures. The resulting cortical volume is covered into a 
triangular tessellation and deformed to more accurately represent grey and white matter 
interface as well as the pial surface. Once the cortex has been reconstructed, this volume is 
registered to a spherical atlas (B. Fischl, SerenoDale, 1999; B. Fischl, Sereno, Tootell, , 1999) 
and parcellated into regions based on the sulcal and gyral structures (Desikan, 2006; Bruce 
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Fischl, 2004). Each T1-weighted scan is segmented into cortical and subcortical regions in 
each hemisphere. Data were then exported into SPSS for analysis (the output of FreeSurfer, 
mm
3
 volumes for each region, was in .dat format and then imported into SPSS).  
 
2.5.2 Manual HC measurements 
HC ROIs were manually outlined on consecutive coronal slices and verified from axial and 
sagittal orientations (Maller, 2007). The anterior tip of the HC until the slice before the 
opening of the crus of the fornix (CF) was measured as the HC head and body and included 
the subiculum, CA1–(4) areas, and dentate gyrus (DG), as described by Watson et al. 
(Watson, 1997), and the HC tail was measured from the slice immediately posterior to that 
which represented the last slice according to the Watson protocol. The internal structure of the 
HC tail is the same as in the head and the body, whereby the cornu ammonis has an analogous 
structure throughout, as does the gyrus dentatus. From the coronal perspective, measuring the 
HC until the CF represents the part of the tail which coincides with the coronal section of the 
pulvinar (which is situated in a supero-medial position). Voluminous choroidal plexuses 
occupy portions of this region, hence care was taken to exclude them laterally from 
volumetric estimates. The HC was then followed posteriorly. On initial slices, the tail appears 
bulgy as an ovoid mass of gray matter on the infero-medial part of the lateral ventricle, and 
more posteriorly it lies flattened on the superior surface of the parahippocampal gyrus. The 
tail was outlined until the fasciolar gyrus becomes the subsplenium gyrus curving around the 
postero-inferior margin of the splenium. The superior border was easy to differentiate from 
the crus of the fornix. The medial and inferior limits were also easily drawn because of the 
contrast between gray/white matter. Relevant images from standard atlases were referred to in 
order to ensure a consistent reference to the boundaries and relevant landmarks for these 
slices of HC. All HC volumes are presented in mm3. 
 
2.5.3 Intra-rater and inter-rater reliability for HC measurements 
HC outlines were traced by two trained researchers blind to the study hypotheses, group 
assignment and subjects' identity. The reliability of the HC measurements was assessed using 
a formula to calculate the intra- and inter-class correlations (intra HC, inter HC) that presumes 
random selection of raters. The two researchers (J.M. and C.M.) each retraced five MRI 
images, which were randomly selected among the images previously traced, and five images 
which belonged to the group previously traced by the other researcher. Intra-HC was 0.942 
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for JM and 0.970 for CM. Inter-HC was 0.939. All these values are well within acceptable 
limits. 
 
2.5.4 Brain volume 
Total brain volume (gray plus white matter) and total intracranial volume (total brain volume 
plus cerebrospinal fluid volume) were computed for each subject using the ‘segment’ m-file 
of the SPM5 software (Wellcome Department of Cognitive Neurology, UK). All outputs were 
manually inspected to ensure accurate and valid data. 
 
2.6 Statistical analyses 
Descriptive analyses were carried out using ANOVA, Student t-test or chi square test based 
on the variable characteristics. Brain measurements were found to be normally distributed 
based on graphs. The Univariate General Linear Model (GLM) was used to compare the brain 
volume of HC and ACC between: 1) currently depressed participants and healthy controls, 2) 
past MDE subjects and healthy controls, 3) currently depressed participants and past MDE 
subjects. We considered the following variables as potentially associated with brain size 
structures: gender, age, education level and total intracranial volume. We chose total 
intracranial volume instead of total brain volume because it seems to be more closely related 
to premorbid brain size (Davis, 1977; Pfefferbaum, 1994).  
The interaction between HC and ACC volumes and gender on the main outcomes (currently 
depressed versus healthy subjects and past MDE versus healthy subjects) was tested. We have 
included in the models: gender, brain volumes and the interaction between gender and brain 
volumes. In the case of the presence of interaction (p≤0.01), we planned to perform stratified 
analyses in males and females. 
All p-values were 2-tailed, and for primary analysis (ANOVA) the significance threshold was 
adjusted using the Benjamini-Hochberg false discovery rate (FDR) correction for multiple 
comparisons, in order to reduce false positive results (q≤0.004). Statistical analyses were 
performed using SPSS version 22.0 for Windows. 
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3. Results 
 
3.1 Sample description 
The mean age of participants was 71.25±4.06 years old. Sample description is shown in Table 
1. Currently depressed individuals have a mean age at onset of 48.43±17.67 (n=68) and a 
mean number of lifetime depressive episodes of 2.01±2.07 (n=69). Past MDE subjects have 
an age at onset of 44.23±14.54 (n=79) and a mean number of lifetime depressive episodes of 
1.80±3.86 (n=79). The two groups were not different on both age at onset (t=1.58, d.f.=145, 
p=0.12) and number of lifetime depressive episodes (t=0.42, d.f.=146, p=0.68). Sixty-six 
currently depressed individuals had a MINI diagnosis of depression. 
Compared to healthy controls, female gender was over-represented among individuals with 
current or past MDE (p<0.0001 in all cases). Moreover, CESD-D total score was higher in 
both currently depressed individuals and past MDE subjects compared to healthy controls 
(p<0.0001 and p=0.001, respectively) and in currently depressed individuals compared to past 
MDE subjects (p<0.0001). Both total brain and total intracranial volumes were reduced in 
participants with current (p=0.001 and p=0.001, respectively) and past MDE (p=0.02 and 
p=0.009, respectively) in comparison to healthy controls. No further difference was found in 
socio-demographic or clinical features between the groups.  
3.2 Current depression  
Results are reported in Table 2. We found left posterior HC volume reduction in currently 
depressed individuals when compared to healthy ones (F=10.84, p=0.001) with manually 
measured HC. However, the difference between these two groups in both HC and ACC 
volumes was not significant by means of the automated method (FreeSurfer), see also Figure 
2. 
We performed supplementary analyses to further explore the reported significant association 
between the decrease in left posterior HC volume and current depression (manual method): i) 
we only included subjects with a MINI diagnosis of depression (n=66) (F=3.93, p=0.048); ii) 
we excluded subjects taking antidepressants (n=24) (F=7.05, p=0.008); iii) we excluded 
subjects with only current antidepressant treatment but without neither a MINI diagnosis of 
current MDE nor a CES-D score ≥16 (n=7) (F=4.83, p=0.008); iv) we added metabolic 
syndrome among covariates (F=9.57, p=0.002). In all these analyses the association remained. 
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3.3 Past MDE 
Comparing individuals with past MDE versus those who never experienced depression, we 
found neither HC nor ACC volume reduction (Table 2 and Figure 2). No difference was 
reported even after comparing currently depressed individuals versus past MDE ones (even 
when only subjects with a MINI diagnosis of depression (n=66) were considered as currently 
depressed subjects).  
 
3.4 Gender 
We tested the interaction between both HC and ACC volumes and gender on both current 
depression and past MDE (versus healthy controls) but we did not find the presence of 
significant interaction. So we did not perform separate analyses for males and females. 
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4. Discussion 
Our study investigated hippocampal (HC) and anterior cingulate cortex (ACC) volume 
differences occurring in depression in older adults of the general population. Our main finding 
is a left posterior HC volume reduction in currently depressed participants compared to 
healthy controls with manual HC measurement. When individuals with a history of past, but 
not current, MDE were compared to those who never experienced depression, no volume 
reduction was found in either the HC or ACC. A similar study reporting higher global brain 
atrophy (especially in HC and thalamus) in current MDD but not in past MDD has been 
recently performed (Geerlings, 2013). However, all their measures were automated and they 
did not correct for multiple comparisons. Moreover, when we slightly changed sub-group 
inclusion criteria (i. including only subjects with a MINI diagnosis of depression; ii. 
excluding subjects taking antidepressants; iii. excluding subjects with only current 
antidepressant treatment but without neither a MINI diagnosis of current MDE nor a CES-D 
score ≥16; iv. adding metabolic syndrome among covariates), the main result remained. 
 
Hippocampus 
Our findings are partly in line with previous studies supporting HC volume reduction in LLD 
(Agudelo, 2015; Andreescu, 2008; Ballmaier, 2008; Bell-McGinty, 2002; Benjamin, 2011; 
Egger, 2008; Lloyd, 2004; Steffens, 2000); however, in our study only the left posterior HC 
volume showed a significant reduction, probably due to the strict methodological adjustments 
we made to avoid type I errors. Neuropsychological studies have linked the alteration of HC 
in depression with impairments in memory (Hickie, 2005), executive functions (T. Frodl, 
2006), but also motivation and emotion (Gray, 1983). Hence, reduced HC volume could play 
an important role in the pathophysiology of elderly depression by participating in affective 
symptoms and cognitive dysfunction that lie at the core of major depression (T. Frodl, 2006). 
Reduced HC volumes have also been associated with a longer course of illness in elderly 
depression (Bell-McGinty, 2002), but the extent to which volume reductions determine 
clinical outcome in MDD remains unknown. However, reduced HC volumes are not specific 
to depression. It has been observed in childhood trauma cohorts (Paquola, 2016) and in other 
psychiatric disorders (Geuze, 2005), such as schizophrenia, post-traumatic stress disorder, 
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borderline personality disorder and obsessive-compulsive disorder, but also in Alzheimer’s 
disease (Jack, 1992), mild cognitive impairment and dementia (Geuze, 2005).  
Importantly, only the manual method found differences in HC volumes. The strength of this 
method is its greater accuracy compared to automated methods (Boccardi, 2011). A study 
comparing manual volumetry to automated HC volumetry using FreeSurfer showed that, 
while FreeSurfer revealed good agreement with manual delineation in detecting HC atrophy, 
volume measured with this software could be 35% larger (Tae, 2008). Therefore, manual HC 
delineation represents the gold-standard helping in the detection of HC atrophy in 
Alzheimer’s disease (Hsu, 2002; Lehmann, 2010; Morey, 2009; Mulder, 2014) and in chronic 
MDD (Tae, 2008). Manual measurement allows a precise segmentation of a structure that is 
still not univocally defined in imaging studies (different delineation protocols are still being 
used in studies analyzing HC) (Konrad, 2009).  
Our results are consistent with studies reporting a volume reduction in the posterior HC 
section of adults suffering from depression (Maller, 2007; Neumeister, 2005; Sivakumar, 
2015). Furthermore, studies indicate greater atrophy in the left HC of depressed individuals 
(Bremner, 2000; Y. I. Sheline, 1996; Yvette I. Sheline, 1999). Dysfunction in the posterior 
HC could lead to neurocognitive deficits implicating spatial learning and memory (Moser, 
1993) impairments that have been highlighted in a neurocognitive study in non-medicated 
symptomatic depressed individuals (Porter, 2003). As for left posterior HC, a recent MRI 
study showed a significantly smaller left posterior HC in individuals suffering late onset 
depression versus controls (Sivakumar, 2015). This could suggest that measuring total HC 
volume without considering its sub-fields is less relevant in the analysis of HC volume 
changes in depression (Huang, 2013; Sivakumar, 2015). Eventually, our findings could be 
linked to the hypothesis based on stress-induced decreases in HC neurogenesis (Jacobs, 
2000). However, HC volumetric reductions might also be due to changes in neuropil, glial 
number, and/or dendritic complexity (Pilar-Cuéllar, 2013). The evidence binding a decrease 
in HC cell proliferation with the pathogenesis of depression is mainly based on neuroimaging 
and postmortem studies (Miller, 2015) and further functional neuroimaging studies are needed 
to establish this potential link.  
 
HC volumetric changes are influenced by factors such as medication effects (Maller, 2007; 
Schmaal, 2015). Since antidepressants suppress the toxic effects of stress on the HC and 
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increase HC neurogenesis (T. S. Frodl, 2008), we controlled the effect of antidepressant 
treatment. The decrease in left posterior HC volume in current depression remained even 
when subjects taking antidepressants were excluded from the analyses. Similarly, when we 
excluded subjects with only current antidepressant treatment but without neither a MINI 
diagnosis of current MDE nor a CES-D score ≥16, the result remained. We are aware that the 
inclusion criteria we chose have an important limitation, because current antidepressant 
treatment cannot be considered as a safe marker of current depression. However, excluding 
persons treated for depression could be problematic as well: treated persons are likely to have 
more severe symptomatology so excluding them could mean eliminate important information 
and significantly weaken the association. The dilemma is that persons treated for depression 
will have had their symptoms artificially lowered, but they would still have been exposed to 
the underlying biological changes and their anatomical correlates.  
Neuroplasticity theory assumes that neural circuits and connections undergo lifelong 
modifications and reorganization in response to external or internal environmental stimuli. 
Adult neurogenesis involves precursors of cell proliferation, migration and differentiation 
mainly occurring in the dentate gyrus of the HC, therefore generating new neurons throughout 
life (Serafini, 2012). Sensitivity to stress is related to affective disorders (Swaab, 2005), and a 
disruption in the stress-axis increases levels of cortisol (Bao, 2008; Swaab, 2005) that 
consecutively seem to disable neurogenesis in HC and affect its volume (Koolschijn, 2009; 
Sapolsky, 2000; Sapolsky, 1986). Stress-induced reduction in neurogenesis may be an 
important factor in precipitating episodes of depression with recovery from depression 
requiring a restoration of the original basal rate of neurogenesis (whether it is due to 
antidepressant treatment or endogenous changes).  
 
Anterior cingulate cortex 
Our results on ACC were inconsistent with previous literature since only a few studies did not 
find any volume reduction in the ACC of depressed patients compared to controls (Bremner, 
2002). In depression, a functional disruption of ACC may lead to an impaired initiation and 
organization of behavior (Devinsky, 1995). Thus, alterations in anterior cingulate could be 
associated with executive and psychomotor symptoms (Devinsky, 1995), often prominent in 
geriatric depression (Jose, 2001). These abnormalities could act as a predisposing factor rather 
than a cause to depression (George S. Alexopoulos, 2008) and the atrophy of dorsal and 
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rostral ACC could favor a chronic course of LLD (Gunning, 2009). Moreover, a recent meta-
analysis reported that LLD tended to be associated with smaller volumes in circumscribed 
frontal and subcortical structures, with the most robust differences being found in thalamic 
volume (Bora, 2012). The lack of reported volume reduction could be linked to our 
conservative approach (FDR correction): in fact, without applying the FRD correction, we 
would be able to detect a lower right caudal ACC volume in currently depressed versus past 
MDE individuals (p=0.01).  
Strengths and limitations 
This paper has some consistent strengths. Our study is one of the very few that evaluated the 
association between lifetime depression and brain volume differences using MRI in a large 
community based older adults’ sample (n=516). We focused on the two brain regions most 
consistently associated with volume reductions in depression and used two types of 
measurement for the HC: automated and manual (in particular, the fact that we also manually 
segmented the HC is a major strength of the study as it is the gold standard). We reduced 
selection bias and information bias using structured interviews and excluding participants 
with dementia. Furthermore, we used a highly conservative approach (FDR correction), not 
applied in the majority of previous studies, even if our analyses were mainly confirmatory and 
not explorative. Due to the design of our study we were able to consider current and past 
MDE. The most important confounders were taken into account. Hence, even if the 
association between depression and reduced hippocampal volumes is well established, this 
study reported that the reduction was isolated to the left posterior hippocampus; moreover, 
this finding validates earlier studies with smaller samples and without FDR correction. 
Limitations should be recognized as well: 1) We did not have any information on the length 
and severity of the episodes nor on the duration of treatment, which are factors known to 
influence cerebral volume changes. Moreover, the course of depression at the time of 
assessment was not known. Finally, we could not consider the number of suicidal attempts, 
the lifetime history of electroconvulsive therapy, the lifetime use of lithium and 
antidepressants and their dosage, all factors influencing brain volumes. 2) The study is cross-
sectional so it is only possible to establish co-occurrence and not causality. In particular, 
individuals with past MDE might never have had smaller HC volumes, so our hypothesis of a 
HC volume recovery would need to be verified in a longitudinal setting. 3) While we have 
adjusted for a number of correlates of HC volume change, the possibility that other clinical 
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and life-style factors may have confounded the association remains. For example, it cannot be 
excluded that the reduced left posterior HC volume, found in currently depressed participants 
and not in past MDE ones, could be due to age atrophy that leads to depression. 4) We 
reported no difference surviving FDR correction when we compared currently depressed 
versus past MDE individuals; however, not considering FDR correction, a small difference 
was present (p=0.03); 5) The scanner used (1.5 T GE Signa) is quite old, however it still 
generated excellent quality data; 6) Even if the sample is large, the size of some groups is 
small (e.g., past MDE subjects n=79).  
5. Conclusions 
Left posterior HC volume reduction was reported in subjects with late life depression but not 
in subjects with past MDE compared to healthy controls. This could be linked to brain 
neuroplasticity. Furthermore, this volume reduction has been detected only when the HC was 
measured using the manual method. This could indicate that the actual accuracy of automated 
methods did not yet match that of the manual one. Future large studies using newer versions 
of FreeSurfer would be interesting. It would be stimulating in the future to have prospective 
imaging studies investigating the severity of MDE and its evolution in depressed older adults.  
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Figures 
Figure 1. Flow chart of the inclusion/exclusion process of participants (MRI: magnetic 
resonance imaging; MINI: Mini International Neuropsychiatric Interview; MDE: major 
depressive episode). They have been included: currently depressed subjects (n=150), subjects 
with a past lifetime history of major depressive episode (n=79), and healthy controls (n=287). 
Figure 2. Hippocampal volumes (both FreeSurfer and manual method) in the three groups: 
currently depressed subjects, subjects with a past lifetime history of major depressive episode, 
and healthy controls (MDE: major depressive episode; *: p=0.001). Current depression was 
associated with a lower left posterior hippocampal volume using manual measurement. 
Gender, age, education level, and total intracranial volume have been considered as covariates 
in the analyses. 
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Socio-
demograp
hic and 
clinical 
variables 
Healthy 
controls 
(n=287) 
Currently 
depressed 
(n=150) 
Past MDE 
(n=79) 
 Controls versus 
currently 
depressed 
Controls versus 
past MDE 
Currently 
depressed versus 
past MDE 
 
t/χ2 d.f
. 
p t/χ2 d.f
. 
p t/χ2 d.f
. 
P 
 n, % or mean±SD F/χ2 d.f
. 
 
p 
Gender 
(males) 
173, 60.3 52, 34.7 25, 31.6 36.42 2 <0.00
01 
25.8
7 
1 <0.00
01 
20.4
5 
1 <0.00
01 
0.21 1 0.65 
Age 
(years) 
71.26±4.17 71.63±3.93 70.49±3.86 2.02 2, 
51
3 
0.13 -
0.88 
43
5 
0.38 1.48 36
4 
0.14 2.09 22
7 
0.04 
Education 
(a) 
   8.34 6 0.21 6.21 3 0.10 3.49 3 0.32 0.92 3 0.82 
None-Low  61, 21.3 39, 26.0 22, 28.2             
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Moderate 80, 28.0 46, 30.7 25, 32.1             
High 52, 18.2 33, 22.0 13, 16.7             
Very high 93, 32.5 32, 21.3 18, 23.1             
Total 
brain 
volume 
(cm3) (b)  
1037.50±103
.28 
1002.94±107
.43 
1007.24±83.
74 
6.60 2, 
50
2 
0.001 3.22 42
4 
0.001 2.39 36
0 
0.02 -
0.31 
22
0 
0.76 
Total 
intracrania
l volume 
(cm3) (b) 
1227.47±127
.71 
1184.50±130
.24 
1186.46±101
.68 
7.15 2, 
50
2 
0.001 3.26 42
4 
0.001 2.63 36
0 
0.009 -
0.12 
22
0 
0.91 
MMSE (c) 27.59±1.74 27.31±1.94 27.86±1.65 2.58 2, 
51
2 
0.08 1.52 43
4 
0.13 -
1.23 
36
3 
0.22 -
2.13 
22
7 
0.03 
<26 33, 11.5 25, 16.7 10, 12.7 2.28 2 0.32 2.24 1 0.13 0.07 1 0.78 0.64 1 0.42 
≥26 253, 88.5 125, 83.3 69, 87.3             
CES-D 
total score 
(d) 
7.29±4.20 22.38±8.04 9.12±3.90 373.0
8 
2, 
51
0 
<0.00
01 
-
25.7
3 
43
3 
<0.00
01 
-
3.46 
36
1 
0.001 13.7
4 
22
6 
<0.00
01 
Anxiety 
disorders 
0, 0.0 42, 28.0 31, 39.2 - - -       3.01 1 0.08 
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(MINI) (e) 
Metabolic 
Syndrome 
(f) 
46, 17.2 34, 24.1 13, 17.1 3.13 2 0.21 2.84 1 0.09 0.01 1 0.99 1.43 1 0.23 
Chronic 
Disorders 
(g) 
141, 50.0 85, 58.2 39, 50.6 2.73 2 0.26 2.61 1 0.11 0.10 1 0.92 1.17 1 0.28 
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Table 1. Socio-demographic and clinical features of the sample (MDE: major depressive episode; MMSE: Mini Mental State Examination; CES-
D: Centre for Epidemiologic Studies - Depression Scale; MINI: Mini International Neuropsychiatric Interview). 
(a) Missing: controls=1, currently depressed=0, past MDE=1. 
(b) Missing: controls=4, currently depressed=7, past MDE=0.  
(c) Missing: controls=1, currently depressed=0, past MDE=0.  
(d) Missing: controls=2, currently depressed=0, past MDE=1.  
(e) Missing: controls=1, currently depressed=0, past MDE=0.  
(f) Missing: controls=19, currently depressed=9, past MDE=3.  
(g) Missing: controls=5, currently depressed=4, past MDE=2.  
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Cortical 
ROIs 
Hemisphere Volume (mm3±SD) ANOVA Post hoc analyses 
F p F p F p F p 
 Healthy 
controls 
(n=287) 
Currently 
depressed 
(n=150) 
Past MDE 
(n=79) 
 Controls 
versus 
currently 
depressed 
Controls 
versus past 
MDE 
Currently 
depressed 
versus 
past MDE 
Total 
hippocampus 
(FreeSurfer) 
L 3635.76±487.79 3488.03±525.94 3608.93±447.19 0.96 0.38 1.53 0.22 0.01 0.96 1.05 0.31 
R 3521.79±461.50 3405.16±456.33 3464.65±414.94 0.44 0.65 0.61 0.43 0.28 0.60 0.01 0.93 
Anterior 
hippocampus 
(Manual 
method) 
L 2699.69±386.87 2655.52±415.55 2685.21±346.21 0.45 0.64 0.73 0.39 0.59 0.44 0.05 0.82 
R 2449.81±352.07 2406.12±395.41 2416.18±321.03 0.26 0.77 0.62 0.43 0.15 0.70 0.03 0.86 
Posterior 
hippocampus 
(Manual 
method) 
L 315.95±101.49 283.48±92.68 315.30±95.05 5.63 0.004* 10.84 0.001 0.16 0.69 4.94 0.03 
R 335.72±98.94 316.39±92.22 339.23±102.31 2.18 0.11 4.33 0.04 0.01 0.91 1.70 0.19 
Total 
hippocampus 
(Manual 
method) 
L 2998.24±416.87 2933.24±435.45 3000.52±370.35 0.43 0.65 0.02 0.89 0.66 0.42 0.68 0.41 
R 2769.90±362.06 2720.59±410.23 2755.40±333.16 0.17 0.84 0.19 0.66 0.29 0.59 0.03 0.86 
Rostral 
anterior 
cingulate 
cortex 
L 1747.90±423.19 1649.23±382.29 1644.80±340.74 0.13 0.88 0.16 0.69 0.01 0.96 0.03 0.87 
R 1696.97±449.69 1659.22±477.45 1699.85±497.43 1.86 0.16 1.36 0.24 2.65 0.10 0.72 0.40 
Caudal 
anterior 
cingulate 
cortex 
L 1586.83±381.66 1515.83±366.84 1599.08±388.80 1.15 0.32 0.53 0.46 1.15 0.28 2.17 0.14 
R 1464.51±408.23 1404.53±365.67 1524.89±381.73 2.75 0.06 0.63 0.43 3.09 0.08 6.40 0.01 
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Table 2. Cortical regions of interest in currently depressed subjects, past major depressive episode subjects and controls (ROI: regions of interest; 
MDE: major depressive episode; R: right; L: left). The following variables have been considered as covariates in the analyses: gender, age, 
education level, and total intracranial volume. *: the ANOVA significance threshold was adjusted using the Benjamini-Hochberg false discovery 
rate (FDR) (q≤0.004). 
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Participants without MRI 
scan (n = 1202) 
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- Participants with dementia (n = 
15) 
- Participants without MINI at 
baseline (n = 16)  
- Participants with other MINI 
diagnoses (n = 114) 
Screened participants  
(n = 661) 
Healthy controls 
 (n = 287) 
 Currently depressed 
subjects (n = 150) 
Past MDE subjects 
 (n = 79) 
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Total
hippocampus
(FreeSurfer) left
 Total
hippocampus
(FreeSurfer)
right
 Total
hippocampus
(Manual
method) left
 Total
hippocampus
(Manual
method) right
 Anterior
hippocampus
(Manual
method) left
 Anterior
hippocampus
(Manual
method) right
 Posterior
hippocampus
(Manual
method) left
 Posterior
hippocampus
(Manual
method) right
Controls 3635,76 3521,79 2998,24 2769,9 2699,69 2449,81 315,95 335,72
Past MDE subjects 3608,93 3464,65 3000,52 2755,4 2685,21 2416,18 315,3 339,23
Currently depressed subjects 3488,03 3405,16 2933,24 2720,59 2655,52 2406,12 283,48 316,39
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